Korean Circ J.
2024 Dec;54(12):822-824. 10.4070/kcj.2024.0309.
Navigating the Efficacy and Safety of Oral Anticoagulation Use for Stroke Prevention in Very Elderly Patients With Atrial Fibrillation
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- 2School of Convergence and Innovation in Technology and Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Korea
- 3Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
- 4Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
- KMID: 2563796
- DOI: http://doi.org/10.4070/kcj.2024.0309
Reference
-
1. Chao TF, Liu CJ, Lin YJ, et al. Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study. Circulation. 2018; 138:37–47. PMID: 29490992.
Article2. Romiti GF, Proietti M, Bonini N, et al. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry Phase II and III. Thromb Haemost. 2022; 122:2030–2041. PMID: 36037828.
Article3. Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L. The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Thromb Haemost. 2024; 124:135–148. PMID: 37369234.
Article4. Zheng Y, Li S, Liu X, Lip GY, Guo L, Zhu W. Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis. Thromb Haemost. 2023.
Article5. Choi SH, Lee YC, Baek YS. The efficacy and safety of NOAC in very elderly atrial fibrillation patients: data from the Korean national health insurance cohort registry. Korean Circ J. 2024; 54:811–821. PMID: 39434362.
Article6. Sulaiman S, Roy K, Wang H, et al. Left atrial appendage occlusion in the elderly: insights from PROTECT-AF, PREVAIL, and continuous access registries. JACC Clin Electrophysiol. 2023; 9:669–676. PMID: 36890047.7. Kang DS, Yang PS, Kim D, et al. Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb Haemost. 2024; 124:883–892. PMID: 38423097.
Article8. Kang DS, Yang PS, Kim D, et al. Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects. Thromb Haemost. 2024; 124:842–851. PMID: 38359877.
Article9. Romiti GF, Guo Y, Corica B, et al. Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial. Thromb Haemost. 2023; 123:1042–1048. PMID: 37247623.
Article10. Chao TF, Joung B, Takahashi Y, et al. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022; 122:20–47. PMID: 34773920.
Article11. Wang Y, Guo Y, Qin M, et al. 2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): Executive Summary. Thromb Haemost. 2024; 124:897–911. PMID: 38744425.
Article
